Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
ALAN ALLMAN ASSOCIATES	AAA	Euronext Paris +1 Other	1,104	8.9 EUR	Stock
ALAN ALLMAN ASSOCIATES	0HNG	London S.E.	0	4.54 EUR
ALAN SCOTT ENTERPRISES LIMITED	ALANSCOTT	Bombay S.E.	3,731	72.79 INR	Stock
ALAN ABP0B23	48BM	London S.E.	-	- %	Bond
ALAN ABP0B23		Börse Stuttgart	-	- %	Bond

News (176)

Transcript : Roche Holding AG, Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024	24/04
Invitation to Roche's First Quarter Sales 2024 Presentation	25/03	AQ
Transcript : Roche Holding AG, 2023 Earnings Call, Feb 01, 2024	01/02
Reminder, Invitation to Roche's Full Year Results 2023 Presentation	26/01	AQ
Invitation to Roche's Full Year Results 2023 Presentation	20/12	AQ
Roche : Invitation to Roche’s Full Year Results 2023 Presentation	19/12	PU
Transcript : Roche Holding AG - Special Call	29/11
Reminder: Invitation to Roche’s IR Digitalization Day	22/11	PU
Roche : Invitation to Roche’s IR Digitalization Day	01/11	PU
Transcript : Roche Holding AG, Q3 2023 Sales/ Trading Statement Call, Oct 19, 2023	19/23/19
Transcript : Roche Holding AG - Special Call	11/23/11
Transcript : Roche Holding AG, H1 2023 Earnings Call, Jul 27, 2023	27/23/27
Roche CFO flags need to bolster late-stage drug development	27/23/27	RE
Transcript : Roche Holding AG - Special Call	23/23/23
Reminder: Invitation to Roche’s virtual ESG event: Environmental Sustainability	15/23/15	PU
Transcript : Roche Holding AG, Q1 2023 Sales/ Trading Statement Call, Apr 26, 2023	26/23/26
Reminder: Invitation to Roche’s First Quarter Sales 2023 Webinar	19/23/19	PU
Roche : Invitation to Roche’s First Quarter Sales 2023 Webinar	27/23/27	PU
Transcript : Roche Holding AG, 2022 Earnings Call, Feb 02, 2023	02/23/02
Reminder: Invitation to Roche’s Full Year Results 2022 Presentation	26/23/26	PU
Invitation to Roche's Full Year Results 2022 Presentation	22/22/22	AQ
Transcript : Roche Holding AG, Q3 2022 Sales/ Trading Statement Call, Oct 18, 2022	18/22/18
Invitation to Roche's 3rd Quarter Sales 2022 Webinar	20/22/20	AQ
Transcript : Roche Holding AG, H1 2022 Earnings Call, Jul 21, 2022	21/22/21
Transcript : Roche Holding AG, Q1 2022 Sales/ Trading Statement Call, Apr 25, 2022	25/22/25
Transcript : Roche Holding AG, 2021 Earnings Call, Feb 03, 2022	03/22/03
Reminder: Invitation to Roche’s Full Year Results 2021 Presentation	28/22/28	PU
Roche : Invitation to Roche’s Full Year Results 2021 Presentation	04/22/04	PU
AWS Supports Roche in Harnessing the Power of Health Data at Scale	30/21/30	BU
Transcript : Roche Holding AG - Special Call	17/21/17
Reminder: Invitation to Roche’s Virtual Event "Digitalization along the value chain"	11/21/11	PU
Transcript : Roche Holding AG, Q3 2021 Sales/ Trading Statement Call, Oct 20, 2021	20/21/20
Roche : Invitation to Roche’s Virtual Event "Digitalization along the value chain"	14/21/14	PU
Reminder: Invitation to Roche’s 3rd Quarter Sales 2021 Webinar	13/21/13	PU
Roche : Invitation to Roche’s 3rd Quarter Sales 2021 Webinar	20/21/20	PU
Transcript : Roche Holding AG, H1 2021 Earnings Call, Jul 22, 2021	22/21/22
Honoring Healthcare Heroes	20/21/20	PR
Reminder: Invitation to Roche’s Half Year Results 2021 Presentation	16/21/16	PU
Roche : Invitation to Roche’s Half Year Results 2021 Presentation	25/21/25	PU
Transcript : Roche Holding AG, Q1 2021 Sales/ Trading Statement Call, Apr 21, 2021	21/21/21
Reminder: Invitation to Roche’s First Quarter Sales 2021 Webinar	14/21/14	PU
Roche : Invitation to Roche’s First Quarter Sales 2021 Webinar	22/21/22	PU
Transcript : Roche Holding AG, 2020 Earnings Call, Feb 04, 2021	04/21/04
Roche : Full-Year 2020 Presentation with appendix	04/21/04	PU
Roche : Full-Year 2020 Presentation without appendix	04/21/04	PU

1234NextSee all

Companies (3)

ALAN SCOTT ENTERPRISES LIMITED 3 M $

Alan Scott Enterprises Limited, formerly Alan Scott lndustriess Limited, is an India-based company. It is focused on health and hygiene equipment for use in hospitals and homes. The Company is primarily engaged in the business of manufacturing equipment f ...

REMEDY ENTERTAINMENT OYJ 281 M $

Remedy Entertainment Oyj is a Finland-based game developer. The Company creates cinematic story-driven action console and computer games, which are published by partners, such as Microsoft, Rockstar Games and Smile Gate. The Companyâs titles include Dea ...

ALAN ALLMAN ASSOCIATES 439 M $

Alan Allman Associates is an ecosystem of strong brands, specializing in digital transformation, created in 2009 through acquisitions and internal performance development in the consulting world. The Ecosystem maintains a network of dynamic, value-creatin ...

Insiders

Alan Hippe

Dr. Alan Hippe is a Chief Financial & Information Technology Officer at Roche Holding AG, a Chairman-Supervisory Board at Roche Kapitalmarkt AG and a Chief Financial Officer at Roche Group. He is on the Board of Directors at Jacobs Holding AG, Roche Holdings, Inc., Colosseum Dental Group, Genentech, Inc. and Zahn Parent LLC. Dr. Hippe was previously employed as a CFO, Head-Controlling & Investor Relations by ThyssenKrupp AG, a Vice Chairman-Executive Board by FirstService Residential Florida, Inc., a President by Continental Tire the Americas LLC, a Chief Financial Officer by Continental AG, a Head-Controlling & IT Systems by AVECO Holding AG, a Senior VP-Controlling, Finance & Accounting by Fraport AG Stiftung ProRegion, a Director-Supervisory Board by Landesbank Hessen-Thüringen Girozentrale, a Chairman-Supervisory Board by Thyssenkrupp Reinsurance AG, a Chairman-Supervisory Board by ThyssenKrupp Risk & Insurance Services GmbH, and a Member-Supervisory Board by Voith GmbH. He received his doctorate degree from The Johannes Gutenberg University of Mainz.

Steffen Hippe has worked as a Senior Executive-Sales & Marketing at dtp entertainment AG since 1995.

Friedrich Hippe

No results for this search